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Despite advances in the pharmacologic and interventional treatment of coronary artery
disease (CAD), atherosclerosis remains the leading cause of death in Western societies.
X-ray coronary angiography has been the modality of choice for diagnosing the presence
and extent of CAD. However, this technique is invasive and provides limited information on
the composition of atherosclerotic plaque. Coronary computed tomography angiography
(CCTA) and cardiac magnetic resonance (CMR) have emerged as promising non-invasive
techniques for the clinical imaging of CAD. Hereby, CCTA allows for visualization of
coronary calcification, lumen narrowing and atherosclerotic plaque composition. In this
regard, data from the CONFIRM Registry recently demonstrated that both atherosclerotic
plaque burden and lumen narrowing exhibit incremental value for the prediction of
future cardiac events. However, due to technical limitations with CCTA, resulting in false
positive or negative results in the presence of severe calcification or motion artifacts,
this technique cannot entirely replace invasive angiography at the present time. CMR on
the other hand, provides accurate assessment of the myocardial function due to its high
spatial and temporal resolution and intrinsic blood-to-tissue contrast. Hereby, regional wall
motion and perfusion abnormalities, during dobutamine or vasodilator stress, precede the
development of ST-segment depression and anginal symptoms enabling the detection
of functionally significant CAD. While CT generally offers better spatial resolution, the
versatility of CMR can provide information on myocardial function, perfusion, and viability,
all without ionizing radiation for the patients. Technical developments with these 2
non-invasive imaging tools and their current implementation in the clinical imaging of CAD
will be presented and discussed herein.
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INTRODUCTION
Despite major advances in the treatment of coronary artery dis-
ease (CAD), it still remains one of the leading causes of death in
Western societies (Murray and Lopez, 1997;Myerburg et al., 1997;
Naghavi et al., 2003). The role of inflammation and the key role
of plaque macrophages in all stages of atherosclerosis is widely
appreciated (Libby et al., 2002; Swirski et al., 2006). Such inflamed
atherosclerotic plaques typically exhibit a lipid-rich pool, over-
expression of collagenases and metalloptroteinases and a thin
fibrotic cap (van Rugge et al., 1993). The secretion of proteolytic
enzymes by lesional macrophages can cause destabilization of cap
tissues, resulting in plaque rupture (Figure 1).
X-ray coronary angiography is the current clinical gold-
standard technique for the detection of CAD. Coronary angiog-
raphy provides an accurate measure of stenosis. However, this
technique is invasive and almost entirely relies on anatomic struc-
ture of the vascular lumen (Vallabhajosula and Fuster, 1997),
providing limited information on the composition of the arterial
wall (Fuster et al., 1992; Topol and Nissen, 1995). Furthermore,
the phenomenon of vascular remodeling decreases the sensitivity
of coronary angiography to detect the true atherosclerotic plaque
burden. Revascularization techniques of coronary artery bypass
surgery (CABG) and percutaneous coronary interventions (PCI)
are currently guided by findings provided by X-ray angiography,
and therefore target high-grade coronary lesions. However, acute
coronary syndromes most commonly result from the rupture of
plaques that are angiographically modest in severity (non-critical
stenoses) (Fuster et al., 1992; Korosoglou et al., 2008a). Therefore,
the currently used revascularization strategies may do little to
prevent future coronary events (Libby, 2001; Boden et al., 2007).
CARDIAC MAGNETIC RESONANCE IMAGING
Cardiac Magnetic Resonance (CMR) can provide non-invasive
imaging with sub-millimeter spatial resolution and high blood-
to-tissue contrast (Toussaint et al., 1996). Due to its non-invasive
nature, high intrinsic contrast and the absence of radiation
exposure for the patients, CMR is to date the preferred tech-
nique for the assessment of cardiac morphology and function.
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FIGURE 1 | The role of inflammation in atherosclerotic disease. Macrophages engulfing oxidized LDL transform to foam cells (A). The secretion of
metalloptroteinases subsequently causes destabilization of cap tissues, resulting in plaque rupture (B).
In this regard, the versatility of CMR can provide assessment of
myocardial function, perfusion, viability and if required cardiac
metabolism within a single “one stop shop” non-invasive exam-
ination. Furthermore, its tomographic nature provides excellent
comparability between perfusion and function of correspond-
ing myocardial segments and high reproducibility of the acquired
results.
DIAGNOSIS OF CORONARY ARTERY DISEASE
Modern CMR 1.5 & 3.0 Tesla clinical scanners provide high
temporal (∼40ms) and spatial (< 1.0∗1.0mm in plane) resolu-
tion for the assessment of cardiac function. The latter is almost
10-fold higher compared to competing nuclear scintigraphy tech-
niques. Although earlier CMR studies had limitations, such as
poor slice coverage and low temporal resolution, limiting the
detection of CAD, subsequent data demonstrated that CMR com-
pares favorably to SPECT for the detection ofmyocardial ischemia
(Schwitter et al., 2001, 2012, 2013; Wagner et al., 2003). In a
recent prospective, real-world clinical trial, which included 752
consecutive patients, CMR exhibited significantly higher diagnos-
tic accuracy compared to SPECT for CAD detection (Greenwood
et al., 2012).
Detection of CAD using CMR is mainly based on the eval-
uation of the functional significance of coronary artery stenosis
during pharmacologic stress testing with either adenosine or
dipyridamole, i.e., coronary vasodilators, or dobutamine, which is
a synthetic ß-adrenergic stimulator. Using stress CMR, inducible
myocardial ischemia can be detected in form of inducible wall
motion abnormalities during dobutamine stress or in form of
perfusion deficits during vasodilator stress, which both precede
the development of ST-segment depression and anginal symp-
toms in the ischemic cascade (Figure 2) and have been reported
to accurately detect functionally significant CAD (Pennell et al.,
1990, 1992; van Rugge et al., 1993, 1994; Hundley et al., 1999;
Nagel et al., 1999, 2003; Schwitter et al., 2001; Schalla et al.,
2002; Doyle et al., 2003; Ishida et al., 2003; Rerkpattanapipat
et al., 2003; Giang et al., 2004; Kawase et al., 2004; Paetsch
et al., 2004, 2006; Plein et al., 2004, 2005; Takase et al., 2004;
FIGURE 2 | Temporal sequence of events in terms of metabolic &
myocardial dysfunction during ischemia.
Sakuma et al., 2005; Cury et al., 2006; Jahnke et al., 2006; Klem
et al., 2006; Pilz et al., 2006; reviewed in Nandalur et al., 2007).
Flow charts for these 2 forms of pharmacologic stress CMR
with corresponding time spent are illustrated in Figures 3A,B
for dobutamine and adenosine stress CMR, respectively. Due
to its tomographic nature, CMR allows for sequential acquisi-
tion of identical slices (each segment at baseline serves as its
own control during peak stress), providing the reproducible and
accurate assessment of wall motion and strain response during
dobutamine stress testing. Similarly, myocardial perfusion can
be assessed in identical slices during baseline and pharmacologic
hyperemia.
In a meta-analysis including 14 dobutamine and 24 adeno-
sine stress CMR studies with 754 and 1516 patients, respectively
sensitivities and specificities of 83% (95% confidence interval of
79–88%), 86% (95% confidence interval of 81–91%) and of 91%
(95% confidence interval of 88–94%) and 81% (95% confidence
interval of 77–85%), respectively were reported (Tables 1, 2).
Especially after exclusion of studies utilizing dipyridamole as a
stressor, the assessment of inducible wall motion abnormalities
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FIGURE 3 | Flow chart illustrating the time course of adenosine perfusion and dobutamine stress CMR examinations (A,B).
Table 1 | Studies performed with dobutamine stress CMR for the detection of CAD by inducible wall motion abnormalities.
Study Stressor(s) Number of MR-scanner Definition of Sensitivity (%) Specificity (%)
patients relevant stenosis (%) with 95%CI with 95%CI
Hundley et al., 1999 Dobutamine/Atropin 41 GE 1.5T >50 83 (86–93) 83 (36–100)
Jahnke et al., 2006 Dobutamine 40 Philips 1.5T ≥50 83 (51–97) 89 (71–97)
Nagel et al., 1999 Dobutamine 172 Philips 1.5T ≥50 86 (78–92) 86 (75–93)
Paetsch et al., 2004 Dobutamine/Atropin 79 Philips 1.5T >50 89 (77–96) 81 (61–93)
Paetsch et al., 2006 Dobutamine 150 Philips 1.5T ≥50 78 (67–87) 88 (78–94)
Pennell et al., 1992 Dobutamine 25 Picker 0.5T ≥50 91 (71–99) 100 (29–100)
Rerkpattanapipat et al., 2003 Exercise 27 GE 1.5T >70 79 (49–95) 85 (55–98)
Schalla et al., 2002 Dobutamine 22 Philips 1.5T >75 81 (54–96) 83 (36–100)
van Rugge et al., 1993 Dobutamine 45 Philips 1.5T >50 81 (65–92) 100 (63–100)
van Rugge et al., 1994 Dobutamine 39 Philips 1.5T ≥50 91 (76–98) 83 (36–100)
Pooled data Dobutamine ± Atropin 680 ≥50–75 85 (82–90) 86 (81–91)
exhibited an improved sensitivity of 85% (95% confidence inter-
val of 82–90%) without a loss in terms of specificity. Furthermore,
in a direct comparison between adenosine and dobutamine stress
CMR in 79 consecutive patients with suspected or known CAD,
the analysis of inducible wall motion abnormalities during dobu-
tamine CMR offered the best trade-off between sensitivity and
specificity (Paetsch et al., 2004). In this regard, the latter provided
sensitivity of 89% and specificity of 80% for the identification of
patients with significant CAD.
An example of a patient with inducible wall motion
abnormality of the anterior-septal apical wall during peak dobu-
tamine stress CMR is illustrated in Figures 4A–D. Corresponding
angiographic images, demonstrating collateralized occlusion of
the LAD can be appreciated in Figures 4E,F.
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Table 2 | Vasodilator stress perfusion CMR for the detection of CAD.
Study Stressor(s) Number of MR-scanner Definition of Sensitivity (%) Specificity (%)
patients relevant stenosis (%) with 95%CI with 95%CI
Cury et al., 2006 Dipyridamole 47 GE 1.5T ≥70 87 (74–94) 89 (80–95)
Doyle et al., 2003 Dipyridamole 199 Philips 1.5T ≥70 58 (37–77) 78 (71–84)
Giang et al., 2004 Adenosine 44 GE 1.5T ≥50 93 (77–99) 75 (48–92)
Pennell et al., 1990 Dipyridamole 40 Picker 0.5T Not specified 62 (45–77) 100 (3–100)
Ishida et al., 2003 Dipyridamole 104 GE 1.5T ≥70 90 (81–95) 85 (67–94)
Kawase et al., 2004 Nicorandil 50 Philips 1.5T >70 94 (80–99) 94 (71–100)
Klem et al., 2006 Adenosine 95 Siemens 1.5T ≥70 89 (75–97) 87 (76–95)
Nagel et al., 2003 Adenosine 90 Philips 1.5T ≥75 88 (75–96) 90 (77–97)
Pilz et al., 2006 Adenosine 176 GE 1.5T >70 96 (91–99) 83 (71–91)
Plein et al., 2004 Adenosine 71 Philips 1.5T ≥70 96 (88–100) 83 (52–98)
Plein et al., 2005 Adenosine 92 Philips 1.5T >70 88 (77–95) 82 (52–90)
Sakuma et al., 2005 Dipyridamole 40 Siemens 1.5T >70 81 (58–95) 68 (43–87)
Schwitter et al., 2001 Dipyridamole 48 GE 1.5T ≥50 87 (71–95) 85 (35–93)
Takase et al., 2004 Dipyridamole 102 GE 1.5T >50 93 (85–98) 85 (65–96)
Paetsch et al., 2004 Adenosine 79 Philips 1.5T >50 91 (79–97) 62 (41–80)
Pooled data Vasodilator stress 1237 91 (88–94) 81 (77–85)
FIGURE 4 | Patient undergoing DCMR for suspected progression of CAD
after PCI and stent placement in the LAD two years ago.During peak DCMR
inducible wall motion abnormality of the LV-apex and anterior-septal wall can be
observed (normal wall motion at baseline in A,B and inducible akinesia during
peak stress (red arrows in C,D). Subsequent coronary angiography
demonstrates collateralized occlusion of the LAD (red arrows in E,F).
Despite the high diagnostic value and reproducibility of stress
CMR (Paetsch et al., 2006), and its in the meanwhile wide accep-
tance among cardiologists in the clinical practice, the assessment
of cine images relies on visual interpretation of regional wall
motion, which is subjective and depends on the experience of
the readers. Recently, Strain-Encoded-MRI (SENC) has been
proposed for the objective color coded evaluation of regional
myocardial strain. Using SENC, myocardial deformation can
be assessed visually using a color coded scale, whereas strain
and strain rate can be quantified in circumferential and longi-
tudinal direction. The ability of SENC to quantify myocardial
strain has been validated in experimental and in clinical set-
tings (Kraitchman et al., 2003; Pan et al., 2006; Korosoglou
et al., 2008b, 2009a,b,c, 2010a, 2011a; Youssef et al., 2008;
Neizel et al., 2009) and this technique favorably compares over
more conventional CMR tagging sequences in terms of tem-
poral resolution, total scan duration and time-spent required
for the post-processing of the acquired data. In a direct com-
parison of conventional tagging to SENC, the latter demon-
strated non-inferior overall accuracy for the detection of func-
tional significant CAD. Furthermore, studying 101 consecutive
patients, we previously demonstrated the ability of the direct
color coded visualization of strain on SENC images to enhance
the sensitivity of dobutamine stress CMR (86 vs. 98%, p <
0.05) for the detection of obstructive CAD (Korosoglou et al.,
2009b). Interestingly, quantitative myocardial strain rate already
decreased with moderate 40–60% coronary artery stenosis, before
relevant reduction of myocardial strain and the occurrence of evi-
dent inducible wall abnormalities by conventional cine imaging.
In addition, SENC enabled the detection of functional signifi-
cant CAD already during intermediate dobutamine stress CMR
(at 20µg/kg of body weight), which may provide improved
patient safety within a lower time spent (Korosoglou et al.,
2010a).
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An example of a patient with an increasing strain abnor-
mality in the anterior-septal wall during dobutamine stress
(Figures 5A,B; red arrows in Figure 5B) can be appreciated in
Figure 5. The presence of a high grade left anterior descending
(LAD) stenosis was confirmed by coronary angiography (red and
blue arrows depicting high grade lesions in the proximal and mid
part of the LAD, respectively in Figure 5C).
Similar to the assessment of wall motion abnormalities, most
CMR centers perform visual analysis of perfusion scans for the
diagnosis of inducible myocardial ischemia in the clinical routine.
In this regard, the transmural extent of a perfusion deficit is deter-
mined from dynamic images showing the maximum extent of
regional hypoenhancement. Hereby, increase in regional hypoen-
hancement during adenosine or dypiridamole stress (≥ 25%
increase in hypoenhancement transmurality compared to base-
line scans) in at least one myocardial segment, which persists
for ≥ 5 consecutive image frames, is considered as indicative of
inducible ischemia (Korosoglou et al., 2010b). Several studies also
demonstrated the value of myocardial perfusion assessment dur-
ing high dose dobutamine stress CMR for the detection of CAD,
particularly in patients with left ventricular hypertrophy and con-
centric remodeling (Gebker et al., 2008, 2010). Recently, fully
quantitative stress perfusion CMR was shown to exhibit higher
precision for the detection of obstructive CAD (≥ 70% stenosis)
compared to semi-quantitative and visual assessment (Mordini
et al., 2014). Multi-center studies are now warranted, in order to
investigate the potential of such fully quantitative stress perfusion
algorithms for the diagnostic work-up of patients with suspected
or known CAD in the clinical routine.
Recent studies have also demonstrated the cost-effectiveness
of CMR in the clinical routine. Thus, an economic evaluation
of the CE-MARC study, which showed that CMR has superior
diagnostic accuracy to SPECT (Greenwood et al., 2012, 2014),
demonstrated that CMR is also a cost-effective strategy in patients
with suspected CAD (Walker et al., 2013). In addition, stress
CMR was shown to represent an effective and cost-reducing
strategy in the diagnostic work-up of patients with acute chest
pain and intermediate likelihood for evolving acute coronary syn-
dromes (Miller et al., 2011; Hall et al., 2012). Currently, the early
implementation of CCTA and CMR in the diagnostic process of
patients with suspected non-ST-elevation myocardial infarction
and its influence in terms of diagnostic classification, outcomes,
and cost-effectiveness is investigated in the CARMENTA trial
(Smulders et al., 2013).
ASSESSMENT OF CLINICAL OUTCOMES
Estimating the risk for subsequent cardiac events is of paramount
importance in patients with known or suspected CAD, because
an invasive therapy is warranted for patients with myocardial
ischemia who are at high-risk for future events according to cur-
rent guidelines (Montalescot et al., 2013). Several studies have
previously demonstrated the usefulness of both vasodilator per-
fusion and dobutamine stress CMR for the estimation of clinical
outcomes in patients with CAD (Ingkanisorn et al., 2006; Bodi
et al., 2007; Jahnke et al., 2007, 2012; Pilz et al., 2008; Doesch et al.,
2009; Lerakis et al., 2009; Steel et al., 2009; Vogel-Claussen et al.,
2009; Charoenpanichkit et al., 2010; Korosoglou et al., 2010b;
Bingham and Hachamovitch, 2011; Coelho-Filho et al., 2011;
Gebker et al., 2011, 2012; Kelle et al., 2011; Krittayaphong et al.,
2011; Lo et al., 2011; Lubbers et al., 2012; Bertaso et al., 2013;
Buckert et al., 2013, reviewed in Lipinski et al., 2013). A recent
meta-analysis systematically analyzed these data, including 14
vasodilator, 4 dobutamine studies and 1 study using both adeno-
sine and dobutamine in a total of over 11,500 patients and with a
mean follow-up duration of over 2.5 years (Lipinski et al., 2013).
In this large meta-analysis, patients with inducible ischemia by
stress CMR exhibited a markedly higher risk for future cardiac
events, including myocardial infarction (odds ratio = 7.7) and
cardiovascular death (odds ratio = 7.0) compared to those with-
out inducible wall motion or perfusion abnormalities during
CMR stress testing. The number of patients, mean follow-up
duration, proportion of patients with known CAD and positive
stress test results, as well as the odds ratio for future cardiac
events in patients with inducible wall motion abnormalities or
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FIGURE 5 | Patient with an increasing strain abnormality in the
anterior-septal wall during dobutamine stress CMR (A,B; red arrows
in B). A high grade left anterior descending (LAD) stenosis was
observed by coronary angiography (red and blue arrows depicting high
grade lesions in the proximal and mid part of the artery, respectively
in C).
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perfusion defects are illustrated for each of these studies in
Table 3.
The assessment of myocardial viability using late gadolinium
enhancement (LGE) is an established method for the assessment
of infarct size and for the risk stratification of patients after acute
myocardial infarction and with chronic ischemic heart disease
(Gerber et al., 2002; Selvanayagam et al., 2004; Giannitsis et al.,
2008; Larose et al., 2010). Thus, the presence and extent of LGE in
terms of infarct size and transmurality is predictive of functional
recovery in patients after acute infarction as well as in patients
with chronic infarction who undergo coronary revascularization
procedures. More recently, LGE was shown to be a predictor of
poor cardiac outcomes in patients with suspected CAD and with-
out history of myocardial infarction. In such patients, even small
amounts of subendocardial LGE carried a high risk for future
infarction and cardiac death (Kwong et al., 2006). Furthermore,
LGE has revealed a higher prevalence of such unrecognized infarc-
tion even in community-based cohorts of older individuals and
is associated with increased mortality risk (Barbier et al., 2011;
Schelbert et al., 2012), even if some unrecognized infarctions are
very small. In addition, we and others recently demonstrated that
LGE has complementary value to both adenosine perfusion and
high dose dobutamine CMR for the assessment of CAD and clin-
ical outcomes (Steel et al., 2009; Bingham and Hachamovitch,
2011; Kelle et al., 2013).
An example of a patient with a small unrecognized scar of
the apical anterior-lateral wall without detectable wall motion
abnormality by cine images can be appreciated in Figure 6.
Recent studies also demonstrated the ability of quantitative
myocardial deformation assessment using SENC to estimate car-
diac outcomes (Korosoglou et al., 2011a). Thus, patients with
impaired myocardial deformation exhibited a higher rate of car-
diac death and non-fatal myocardial infarction compared to those
with preserved myocardial deformation by strain and strain rate
(Korosoglou et al., 2011a). Hereby, strain rate seems to better
reflect changes in regional myocardial contractile behavior, in
contrast to alterations in systolic strain, which can be related
to increased heart rate during dobutamine stress or to altered
myocardial loading conditions (Weidemann et al., 2002).
Ongoing clinical trials such as the PROMISE study now aim
at comparing functional stress tests such as CMR and echocar-
diography with anatomical modalities such as CCTA in order to
determine which might be better at finding out who has heart
disease and will require more testing and treatment (https://www.
promisetrial.org/). More than 10,000 have already been enrolled
in this study and first results are expected in 2015.
CARDIAC COMPUTED TOMOGRAPHY (CTA)
Cardiac Computed Tomography Angiography (CCTA) can provide
non-invasive imaging of moving coronary arteries with sub-
millimeter spatial resolution and high signal-to-noise ratio. This
technique has seen rapid progress in its utility for the assessment
of CAD in the last years and can provide delineation of both vessel
lumen and coronary vessel wall. The latter enables the assessment
of atherosclerotic plaque composition, which seems to be of great
importance not only for the diagnostic classification but also for
Table 3 | Studies demonstrating the ability of dobutamine and vasodilator stress CMR for the assessment of clinical outcomes.
Study Mean follow-up Number of Known Proportion of patients Odds ratio in patients
(years) patients CAD (%) with positive stress (%) with positive CMR
DOBUTAMINE STRESS CMR
Charoenpanichkit et al., 2010 6.0 353 Not reported 31 3.1
Gebker et al., 2011 2.1 1167 48 40 11.3
Jahnke et al., 2007 2.3 513 54 41 4.7
Kelle et al., 2011 3.7 1463 52 30 2.9
Korosoglou et al., 2010b 2.0 1473 55 20 5.9
VASODILATOR STRESS CMR
Bertaso et al., 2013 1.8 362 43 25 4.7
Bingham and Hachamovitch, 2011 2.6 908 49 33 1.76
Bodi et al., 2007 1.1 1722 Not reported 41 1.15
Buckert et al., 2013 4.2 1152 Not reported 27 3.21
Coelho-Filho et al., 2011 2.5 405 Not reported 31 17.2
Doesch et al., 2009 2.5 81 100 56 16.6
Ingkanisorn et al., 2006 1.3 135 17 21 30.0
Jahnke et al., 2012 4.8 679 54 48 4.1
Krittayaphong et al., 2011 2.9 1232 12 34 9.7
Lerakis et al., 2009 0.8 103 13 10 Non-estimable
Lo et al., 2011 3.2 203 16 21 7.7
Lubbers et al., 2012 1.8 125 Not reported 10 Non-estimable
Pilz et al., 2008 1.0 218 0 0 Non-estimable
Steel et al., 2009 1.4 254 Not reported 29 8.04
Vogel-Claussen et al., 2009 1.2 27 19 19 Non-estimable
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FIGURE 6 | Patient undergoing CMR with late gadolinium enhancement (LGE) imaging, where a small scar of the apical anterior-lateral wall can be
appreciated (red arrows in G), without detectable wall motion abnormalities in the corresponding cine images (A–F).
the estimation of future cardiac events in patients with suspected
CAD. In contrast to CMR, the administration of iodine contrast
agents is necessary with CCTA for the visualization of cardiac
structures and coronary arteries.
In addition CCTA is associated with radiation exposure for
the patients, which limits its serial applicability, particularly in
younger patients (Einstein et al., 2007). This still raises con-
cerns among physicians and radiologists with CCTA, as it may be
associated with non-negligible lifetime attributable risk of breast
or lung cancer. Therefore, several strategies have been devel-
oped lately in order to reduce the resultant radiation dosages
(Hausleiter et al., 2010; Hosch et al., 2011, 2012).
DIAGNOSIS OF CORONARY ARTERY DISEASE
Several studies have demonstrated the ability of CCTA to detect
anatomically significant CAD with high negative predictive value
and clinically acceptable overall accuracy. Previous studies per-
formed with 16-slice CT scanners, already pointed to the high
negative predictive value of the technique (Nieman et al., 2002;
Ropers et al., 2003; Kuettner et al., 2004; Mollet et al., 2004;
Dewey et al., 2006), i.e., its ability to exclude relevant CAD
with high accuracy (Table 4A). Subsequent studies, performed
with 64-slice scanners confirmed the high negative predictive
value of CCTA for the exclusion of anatomically relevant CAD,
showing overall increased accuracy compared to previous stud-
ies (Heuschmid et al., 2007; Leber et al., 2007; Meijboom et al.,
2007; Ropers et al., 2007; Shabestari et al., 2007; Miller et al.,
2008), (Table 4B). Importantly, the ability of CCTA to detect
CAD using X-Ray angiography as a gold standard is related to
the pre-test probability of the study cohort. In this regard, a neg-
ative CCTA scan can reliably rule out the presence of significant
CAD in patients with a low or intermediate likelihood for CAD,
whereas it does not necessarily provide additional diagnostic
information in patients with high pre-test probability (Meijboom
et al., 2007). This reduction of the negative predictive values in
patients with high disease prevalence was also shown in a compa-
rable study comprising 88 patients (Husmann et al., 2008). Such
high-risk symptomatic patients are likely to proceed to invasive
angiography even if CCTA is negative, since the post-test proba-
bility of significant CAD is still >10%. CCTA therefore appears
to have limited applicability in such patients, who should rather
undergo a functional test as stress CMR for the assessment of
inducible myocardial ischemia prior to invasive diagnostics. In
the same line recent guidelines published by the European Society
of Cardiology (ESC) recommend the usage of CCTA in rather
patients at low intermediate (15–50%) pre-test probability for
CAD, especially in candidates with low and stable heart rate and
with therefore expected good image quality. In addition the pres-
ence of adequate technology and local expertise is important in
this context (Montalescot et al., 2013).
More recent studies, performed with >64-slice CT scanners
confirmed the high negative predictive value of CCTA for the
exclusion of anatomically significant CAD (Dewey et al., 2009;
Chao et al., 2010; Korosoglou et al., 2010c; Achenbach et al., 2011;
Li et al., 2013; Petcherski et al., 2013; Blank et al., 2014). In this
regard, the recent introduction of 640-slice CT scanners allows
for the acquisition of the whole coronary artery tree within one
heart beat so that no stitching is required during image recon-
struction. The use of adaptive iterative dose reduction algorithms
with this systems was shown to allow for coronary CTA with rela-
tively low radiation exposure of 2.0–2.6mSv (Yoo et al., 2013; Di
Cesare et al., 2014).
An example of a high-grade proximal LAD lesion using 256-
slice CCTA can be appreciated in a male patient with atypical
angina using whole-heart (Figure 7A), longitudinal (Figure 7B),
and multi-planar reconstructions (Figures 7C,D). Subsequent
invasive coronary angiography confirmed the presence of the
proximal LAD lesion (Figures 7E,F).
Currently, an individual patient data meta-analysis is intended
within the PROSPERO database, which will include individual
patient data originating from studies comparing CCTA to invasive
X-Ray angiography (Schuetz et al., 2013). This meta-analysis will
possibly address the important question of which patients benefit
most from CCTA in terms of clinical presentation and risk pro-
file. To date, the most frequent indication for CCTA is found in
patients with low or intermediate likelihood for CAD in order to
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avoid unnecessary invasive procedures. Thus, clinicians and radi-
ologist should be aware of limiting factors such as severe coronary
calcification (Gitsioudis et al., 2014), prior PCI and stent place-
ment, arrhythmia and high body-mass-index (Carrabba et al.,
2010), which may result in a higher number of false positive
results, leading to unnecessary invasive diagnostic procedures.
The cost-effectiveness of CCTA for the diagnostic work-up of
patients with suspected CAD was systematically evaluated in a
recent meta-analysis (Zeb et al., 2014). Hereby, CCTA represented
a cost-effective diagnostic strategy in the evaluation of patients
with stable chest pain and CAD prevalence of 10–50%, as well
as in patients with acute chest pain and low risk for obstructive
CAD. In such patients CCTA may be associated with less down-
stream testing, expedited patient management and safe exclusion
of acute coronary syndromes. In patients with CAD prevalence of
≥ 70% however, invasive angiography should rather represent the
Table 4 | Ability of representative 16-, 64- and >64-slice CCTA studies for the detection of anatomically significant CAD.
Study Number of patients Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
(A) 16-SLICE CCTA
Nieman et al., 2002 59 95 86 80 97 90
Ropers et al., 2003 77 92 93 79 97 93
Mollet et al., 2004 128 92 95 79 98 94
Kuettner et al., 2004 60 72 97 72 97 86
Dewey et al., 2006 129 82 90 90 95 87
Overview data 453 72–95 86–90 72–90 ≥95 86–94
(B) 64-SLICE CCTA
Meijboom et al., 2007 254 92 93 60 99 93
Shabestari et al., 2007 143 92 97 77 99 96
Leber et al., 2007 90 90 99 81 99 99
Ropers et al., 2007 100 90 98 79 99 98
Heuschmid et al., 2007 51 96 87 61 99 88
Miller et al., 2008 291 75 93 82 89 n.a
Overview data 929 75–96 87–99 60–82 89–99 88–99
(C) >64-SLICE (128-, 256- & 320-SLICE) CCTA
Blank et al., 2014 65 95 54 47 96 n.a.
Petcherski et al., 2013 121 97 97 75 100 97
Chao et al., 2010 104 94 95 78 99 94
Korosoglou et al., 2010c 27 89 100 100 95 96
Dewey et al., 2009 30 78 98 75 99 97
Li et al., 2013 454 87 97 98 83 96
Achenbach et al., 2011 50 92 98 74 99 95
Overview data 851 78–97 54–100 47–100 ≥95 ≥94
FIGURE 7 | Whole heart reconstruction (A) of a male patient
undergoing CCTA (256-slice iCT scanner, Philips Medical
Systems, Best, The Netherlands) for suspected CAD due to
atypical angina. A high-grade lesion of the proximal (red arrows)
and an intermediate lesion (blue arrows) of the mid LAD can be
appreciated in corresponding longitudinal (B) and curved multi-planar
reconstructions (C,D). Subsequent invasive coronary angiography
confirmed the presence of CAD in the proximal and mid LAD (E,F).
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first line diagnostic modality. In the same line the ROMICAT trial
previously demonstrated that in patients with symptoms sugges-
tive of coronary syndromes, incorporating CCTA into a triage
strategy improved the efficiency of clinical decisionmaking, with-
out resulting in a significant increase of the overall costs of care
(Hoffmann et al., 2012).
ASSESSMENT OF CORONARY PLAQUE COMPOSITION AND RISK
STRATIFICATION
Assessment of plaque composition
Despite the fact that conventional X-ray coronary angiogra-
phy still remains the gold standard for detection of CAD, this
technique provides limited information on the composition of
atherosclerotic plaque (Libby, 2002). CCTA on the other hand,
provides the non-invasive visualization of coronary plaque com-
position with high precision (Achenbach et al., 2004; Voros et al.,
2011). First generation CCTA scanners offered limited ability
for the reliable detection of coronary lesions due to lower spa-
tial and temporal resolution. The development of multi-slice CT
scanners with faster gantry rotation speed, Z-direction focal-spot
sampling and spherical detector design however, helped to cir-
cumvent such limitations (Ong et al., 2006; Stolzmann et al.,
2008; Voros, 2009; Chao et al., 2010; Hsiao et al., 2010; de Graaf
et al., 2010). In addition, recent software developments with
dedicated post-processing tools constituted major steps toward
the reliable and quantitative assessment of atherosclerotic plaque
composition (Mollet et al., 2005; Hamon et al., 2006; Ropers
et al., 2006; Pohle et al., 2007; Schmid et al., 2008; Korosoglou
et al., 2010c). Such software tools allow for the quantitative
assessment of (Murray and Lopez, 1997) total plaque volume
(Myerburg et al., 1997) distribution of calcified and non-calcified
content within the plaque and (Naghavi et al., 2003) mean plaque
density in Hounsfield Units (HU) with low inter-observer vari-
ability and within a reasonable time-spent (Korosoglou et al.,
2010c; Rinehart et al., 2011). Current guidelines of the Society
of Cardiac Computed Tomography (SCCT) introduced a scheme
for the visual characterization of different plaque types for clinical
reporting (Raff et al., 2009). In general, the percentage of cal-
cium content is <20% in non-calcified plaque, between 20 and
80% in party calcified (mixed) plaque and >80% in calcified
plaque. The reproducibility of this qualitative assessment (calci-
fied, non-calcified, mixed plaques) was shown to be good in terms
of both intra- and inter-observer agreement (Lehman et al., 2009;
Rinehart et al., 2011). According to the tissue specific attenua-
tion properties, 3 different plaque components can potentially
be distinguished, including (Murray and Lopez, 1997) lipid-
rich (14–70HU), (Myerburg et al., 1997) fibrotic (71–150HU)
and (Naghavi et al., 2003) calcified components (>150–200HU)
(Pohle et al., 2007). However, there is still a lack of a uni-
form attenuation cut-off values defining these tissue qualities due
to overlapping attenuation intervals, so that lipid and fibrotic
plaque components are often summarized as “non-calcified.”
Representative examples of a partly calcified atherosclerotic coro-
nary plaque can be appreciated in Figure 8. Hereby, the com-
plexity of this plaque in the left main coronary artery can be
appreciated in corresponding multi-planar (Figures 8A,C), lon-
gitudinal (Figure 8B) and circumferential (Figures 8D,E) CCTA
reconstructions. The presence of a high-grade left main lesion can
be appreciated by invasive coronary angiography (Figure 8F).
Estimation of clinical outcomes by CCTA
Several studies evaluated the ability of atherosclerotic plaque
composition assessment by CCTA to estimate cardiac outcomes in
patients with suspected or known CAD and clinically stable chest
pain syndrome (Pundziute et al., 2007; Gaemperli et al., 2008;
Aldrovandi et al., 2009; Carrigan et al., 2009; Gopal et al., 2009;
Hadamitzky et al., 2009; Rubinshtein et al., 2009; van Werkhoven
et al., 2009a, reviewed in Bamberg et al., 2011) and summarized in
Table 5). The recently published meta-analysis, which systemati-
cally reviewed the findings of these studies, included 7335 patients
with stable CAD (Bamberg et al., 2011). Hereby, the presence and
extent of plaque and coronary lesions by CCTA were independent
FIGURE 8 | A party calcified plaque in the left main coronary artery can
be appreciated in corresponding multi-planar (A,C), longitudinal (B) and
circumferential (D,E) CCTA reconstructions (red and blue arrows in B and
C pointing to non-calcified and calcified components of the plaque,
respectively). The presence of a high-grade left main lesion was
subsequently confirmed by invasive coronary angiography (F).
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Table 5 | Studies investigating the ability of CCTA for the assessment of clinical outcomes by evaluation of (A) coronary artery stenosis and (B)
atherosclerotic plaque.
Study Number of Median follow-up Event rate in Event rate in CT Event rate in CT Hazard
patients time (years) all patients (%) positive patients (%) negative patients (%) ratios
(A) PREDICTION OF OUTCOMES BY CORONARY ARTERY STENOSIS
Pundziute et al., 2007 100 2.2 26 58 8 28.0
Gaemperli et al., 2008 220 1.2 23 51 2 12.7
Carrigan et al., 2009 227 2.3 3.5 13 0.5 9.8
Gopal et al., 2009 493 3.3 1.2 6.5 0.1 16.6
Hadamitzky et al., 2009 1150 1.5 1.2 3.3 0.3 16.1
Aldrovandi et al., 2009 187 2.0 5.4 24.3 1.0 34.9
Rubinshtein et al., 2009 545 1.5 6.4 14.5 1.0 10.9
van Werkhoven et al., 2009b 432 1.8 2.9 6.5 2.5 3.6
van Werkhoven et al., 2009a 316 1.8 2.2 6.0 1.7 3.5
Andreini et al., 2012 1304 4.3 2.6 19.9 0 4.8
Motoyama et al., 2009 1059 2.6 0.8 22.3 0.5 22.8
Hadamitzky et al., 2011 2223 2.3 0.9 2.9 0.3 13.5
(B) PREDICTION OF OUTCOMES BY CORONARY PLAQUE
Pundziute et al., 2007 100 2.2 24 30 0 n.a.
Gaemperli et al., 2008 220 1.2 23 28 0 n.a.
Ostrom et al., 2008 2538 6.5 0.5 0.72 0.26 n.a.
van Werkhoven et al., 2009b 432 1.8 1.9 4.9 1.4 n.a.
van Werkhoven et al., 2009a 316 1.8 1.3 3.5 0.64 n.a.
predictors of future cardiovascular events. Based on 252 outcome
events (6% all-cause, 6% cardiovascular mortality, 23% non-fatal
MI, 4% unstable angina and 62% coronary revascularization), the
estimated hazard ratio was 10.7, indicating a more than 10-fold
higher risk among patients with vs. without obstructive CAD. In
addition, subjects with any coronary plaque were at∼4.5-fold risk
for future events, compared to patients without plaque.
In the recently published CONFIRM registry both lumen
narrowing and plaque burden, especially in proximal coronary
segments were predictive of cardiovascular mortality in patients
with suspected CAD (Hadamitzky et al., 2013). In this study,
patients with proximal segments with stenosis >50% exhibited
higher mortality rates (HR = 1.46 with a 95%CI of 1.15–1.87)
compared to those without proximal coronary stenosis. In this
regard, the number of proximal segments with stenosis >50%
and the number of proximal segments with mixed or calcified
plaque were identified as the best predictors of outcome surpass-
ing the value provided by standard clinical variables, including
the Framingham and the Morise score. In addition, the value
of risk assessment in patients with CAD using a CCTA-based
semi-automated plaque assessment has been recently shown
(Versteylen et al., 2013). In this regard, quantitatively assessed
total plaque and total non-calcified volume were predictive for
future acute coronary syndromes, providing incremental value
over clinical risk profiling and conventional CCTA readings.
The role of biomarkers in combination with imaging (bio-imaging)
Fewer studies have investigated the complementary value of
cardiac biomarkers to CCTA imaging findings for the estima-
tion of cardiac outcomes so far. Several biomarkers are used
in clinical routine together with clinical assessment and 12-lead
ECG for the triage of patients with acute coronary syndrome
(ACS). In this regard, cardiac troponins were shown to aid the
diagnostic classification and risk stratification of such patients
(Katus et al., 1991; Korosoglou et al., 2004; Thygesen et al.,
2012). Recently, we and others demonstrated an association
between atherosclerotic plaque composition by CCTA and high-
sensitivity cardiac troponin even in non-ACS patients (Laufer
et al., 2010; Korosoglou et al., 2011b). This association may be
explained by chronic clinically silent rupture of non-calcified
plaque, which results to embolization of atherosclerotic debris
in the microcirculation and to consecutive myocardial micro-
necrosis. In a further experimental setting, HMBG1 (high mobil-
ity group box 1) protein was found to be a critical media-
tor of acute ischemic injury, predicting adverse outcomes after
myocardial infarction (Andrassy et al., 2008, 2011). In addi-
tion, we could show that HMBG1 serum levels are associ-
ated with coronary calcification and with non-calcified plaque
composition in patients with suspected or known stable CAD
(Andrassy et al., 2012).
C-reactive protein (CRP) on the other hand, was previously
proposed as a central mediator in atherosclerotic plaque develop-
ment and vascular inflammation (Zhang et al., 1999). However,
further basic science research questioned such initially proposed
direct atherogenic mechanisms (Clapp et al., 2005; Koike et al.,
2009). In this regard, we and others demonstrated that serum
levels of high sensitivity CRP are only weakly and not indepen-
dently associated with plaque composition (Hamirani et al., 2008;
Blaha et al., 2011; Korosoglou et al., 2011b). More specific inflam-
matory markers of such as HMBG1 could provide a stronger
association with plaque formation in this context. In this regard,
the recently published dal-PLAQUE study demonstrated that
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myeloperoxidase (MPO) levels are associated with carotid plaque
inflammation, assessed using 18F-fluorodeoxyglucose positron
emission tomography/computed tomography (FDG-PET/CT)
(Duivenvoorden et al., 2013). An overview of studies within
the bio-imaging area (Laufer et al., 2010; Blaha et al., 2011;
Korosoglou et al., 2011b; Andrassy et al., 2012; Duivenvoorden
et al., 2013; Nakazato et al., 2013; Voros et al., 2013) is presented in
Table 6. Future studies are now warranted in order to investigate
the ability of CCTA in combination with cardiac or inflammatory
biomarkers for the individualized risk stratification of patients
with presumably stable CAD.
RADIATION EXPOSURE WITH CCTA
Optimal diagnostic image quality with a minimum dosage of
radiation exposure for the patients still represents a major chal-
lenge. In this regard, radiation exposure with CCTA still raises
concerns among physicians, as it may be associated with non-
negligible lifetime attributable risk of breast or lung cancer,
particularly in women and in younger patients (Einstein et al.,
2007). In one of the first studies, which systematically investigated
the radiation dose of CCTA in routine clinical practice, median
CCTA doses were shown to be extremely different among differ-
ent study sites and CT scanners (Hausleiter et al., 2009). Since
then several strategies have been developed to reduce radiation
dose, including dose modulation techniques, prospective ECG
triggering, low-tube voltage CT imaging and iterative reconstruc-
tion algorithms (Hausleiter et al., 2010; Hosch et al., 2011, 2012,
2013). In this regard, the PROTECTION I study demonstrated
that prospective ECG-triggered CCTA can significantly reduce
radiation dose by ∼70%, without influencing image quality when
compared to standard retrospective scans in patients with a
low and stable heart rate (Bischoff et al., 2010). These results
were subsequently confirmed in the multicenter, multivendor,
randomized PROTECTION III study (Hausleiter et al., 2012).
The PROTECTION II study on the other hand, demonstrated
that 100kV low tube voltage CCTA is associated with a further sig-
nificant ∼30% reduction of the resultant radiation exposure with
simultaneously maintained diagnostic image quality (Hausleiter
et al., 2010). More recently, the introduction of prospectively
triggered high-pitch spiral CCTA allowed the acquisition of diag-
nostic images with a resultant radiation exposure of <1mSv in
non-obese patients with low and stable heart rates (Achenbach
et al., 2011). The combination of this new high-pitch spiral
technology with low tube voltage and iterative reconstruction
can further dramatically reduce radiation exposure with CCTA,
achieving an effective dose below 0.1mSv with sufficient image
quality (Schuhbaeck et al., 2013). However, such an ultra-low
protocol may be associated with a non-negligible number of non-
diagnostic segments even in non-obese patients with stable heart
rates. In general CCTA can be nowadays assessed with a radiation
exposure of ∼0.5–1mSv in most patients, by combining the use
of prospective ECG-triggering, low-tube voltage, BMI-adapted
protocols and iterative reconstruction algorithms. Representative
images of a left coronary artery, reconstructed using standard
back filtered (Figure 9A) and iterative algorithms (Figures 9B,C)
with a resultant radiation exposure of 0.4mSv can be appreciated
in Figure 9.
In addition, the value of calcium scoring scans as a filter prior
to CCTA, in order to identify patients with severe calcification
was recently shown to be limited in younger patients with inter-
mediate risk profile. Omitting such calcium scoring pre-scans in
younger patients can contribute to further absolute dose reduc-
tion of ∼0.75–1.0mSv with cardiac CT studies (Gitsioudis et al.,
2014). This is important in light of the clinical applicability of
current low-dose CCTA protocols (as shown in Figure 9) and of
the fact that additional calcium scoring scans resulted in addi-
tional DNA double-strand breaks in recent clinical trials (Brand
et al., 2012).
Table 6 | “Bio-imaging” studies using coronary computed tomography and biomarkers in stable CAD patients.
Bio-markers CT Imaging Number of Main result/ conclusion
technique patients
Laufer et al., 2010 hsTnT 64-slice CT 615 HsTnT strongly is associated with CAD in patients
without ACS.
Korosoglou et al., 2011b hsTnT 256-slice CT 124 HsTnT is closely related to coronary plaque
composition.
Blaha et al., 2011 hsCRP 4-slice CT for CAC 6762 hsCRP is not associated with coronary
calcification.
Duivenvoorden et al., 2013 Myeloperoxidase
(MPO), hsCRP
18FDG-PET/CT 130 MPO levels are associated with carotid plaque
inflammation.
Andrassy et al., 2012 HMBG-1 256-slice CT 152 HMBG1 is associated with the atherosclerotic
plaque composition.
Nakazato et al., 2013 LDL, HDL and
total cholesterol
≥64-slice CT 4575 Non-HDL is associated with non-calcified coronary
plaque.
Voros et al., 2013 ApoB, HDL, LDL 64-sl. MDCT IVUS/VH 60 ApoB and small HDL particles are associated with
larger plaque burden and non-calcified plaque.
CAD, Coronary artery disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ApoB, Apolipoprotein B; hsTnT, high-sensitive Troponin T; hsCRP, high-
sensitive C-reactive protein; MPO, myeloperoxidase; CT, computer tomography; CAC, coronary artery calcification.
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FIGURE 9 | Images of a left coronary artery, reconstructed
using standard back filtered (A) and iterative algorithms
[iDose in B and knowledge based iterative model
reconstruction (IMR) in C] with a resultant radiation
exposure of 0.4mSv. Diagnostic image quality and significant
noise reduction is provided using IMR.
SUMMARY AND CONCLUSIONS
Coronary computed tomography angiography and CMR can
both be regarded as in the meanwhile clinically well-established
techniques for the diagnostic classification and risk stratification
of patients with suspected or known CAD. The strengths of CCTA
are its ability (1) to non-invasively visualize moving coronary ves-
sels with high spatial resolution, excluding significant CAD with
high precision and (2) to assess the composition of atherosclerotic
plaque components. Its main limitation is the resultant radia-
tion exposure for the patients, which limits its serial applicability
particularly in younger patients. However, scientist, clinicians,
and manufacturers managed significant reductions of radiation
exposure in this field within the last 5 years. The strength of
CMR on the other hand, is its ability to assess inducible wall
motion abnormalities and perfusion defects during stress test-
ing aiding the detection of functionally significant CAD. Thus,
it represents the optimal technique for the risk stratification of
patients with suspected CAD and for guiding revascularization
procedures in patients with diagnosed CAD by CCTA or inva-
sive angiography. Current guidelines encourage the liberal use of
both CCTA and CMR as first choice modalities for the diagnos-
tic work-up of patients with low and intermediate likelihood for
CAD in experienced centers.
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